Hif-1α stabilisation has potential as a HDT for treatment of fungal infections but requires appropriate in vitro models that allow both genotypic and phenotypic characterisation of the effects of Hif-1α stabilisation on fungal infection and immune cell behaviour. The gene discussed is HIF1A; the disease is fungal infectious disease.